Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Removing the Main Lung Tumor in Lung Cancer Spread to the Lining

Tests removing the main lung tumor in adults with lung cancer spread to the lining.

Key facts

Who runs it
Fudan University
Where
Shanghai, ChinaSee the site
Trial code
Registry title
Primary Tumor Resection for M1a Stage Lung Cancer
Status
Recruiting
People taking part
66 people, planned
Started
1 Apr 2024
Expected to end
Dec 2027
Type of study
Observational
Record updated
8 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with lung cancer where small spots of cancer on the lung lining were found during surgery. It tests removing the main tumor.

Age
18-80 years (the registry also lists a maximum age of 75 years)
Sex
All sexes can join.
Disease stage
M1a stage lung cancer, confirmed by pathology during or after surgery, with hidden spread to the lung lining (pleura) found during surgery. ECOG score 0 or 1.
Earlier treatment
No earlier lung cancer surgery. First-time treatment, with no earlier radiotherapy or chemotherapy.

Main reasons for not taking part

  • The tumor cannot be completely removed by surgery
  • Other lung cancers or tumors besides this lung cancer, shown by cell or tissue tests
  • Earlier lung cancer surgery
  • Earlier radiotherapy or chemotherapy

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Volunteer to participate in clinical research, willing to follow and able to complete all trial procedures
  • Aged 18-80 years (including critical values) when signing the informed consent form
  • ECOG score 0 or 1
  • No previous lung cancer surgery
  • Intraoperative or postoperative pathological confirmation of M1a stage lung cancer
  • Occult pleural metastasis found during surgery
  • First-time treatment and no radiotherapy or chemotherapy

Who cannot take part

  • Patients who have received radiotherapy or chemotherapy and are not treatment-naive patients
  • Cytological or histological pathology confirms other lung malignancies other than lung cancer
  • Patients who have undergone lung cancer surgery before
  • The lesion cannot be completely removed surgically

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in China

  • Fudan University Cancer CenterShanghai, ChinaContact: Chen Haiquan, MDTaking people

About the trial

What the trial wants to find out

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1023. This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery, and to more accurately evaluate whether primary lesion resection can improve the OS and quality of life of the corresponding patients.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Primary Tumor Resection for M1a Stage Lung Cancer With Occult Pleural Dissemination Discovered During Surgery: a Prospective, Single-arm, Multi-center, Phase Ⅱ Trial
Plain-language title
Removing the Main Lung Tumor in Lung Cancer Spread to the LiningGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06547710, who can take part
Record updated
8 July 2026